An incurable disease
A new book explains how health care can become both more expensive and more affordable
HEALTH-CARE expenditure in America is growing at a disturbing rate: in 1960 it was just over 5% of GDP, in 2011 almost 18%. By 2105 the number could reach 60%, according to William Baumol of New York University’s Stern School of Business. Incredible? It is simply the result of extrapolating the impact of a phenomenon Mr Baumol has become famous for identifying: “cost disease”. His new book* gives a nuanced diagnosis, offerings both a vision of a high-cost future and a large dose of optimism. The cost disease may be incurable, but it is also survivable—if treated correctly.
This article appeared in the Finance & economics section of the print edition under the headline “An incurable disease”
From the September 29th 2012 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Finance & economics
The stockmarket rout may not be over
As investors pause for breath, we assess what could turn a correction into a crash
Why Japanese stocks are on a rollercoaster ride
Volatility in global markets continues
Why Japanese markets have plummeted
The global rout continues, with the Topix experiencing its worst day since 1987
Swing-state economies are doing just fine
They would be doing even better if the Biden-Harris administration had been more cynical
Can Kamala Harris win on the economy?
A visit to a crucial swing state reveals the problems she will face
Why fear is sweeping markets everywhere
American and Japanese indices have taken a battering. So have banks and gold